Tag: Urticaria

Briquilimab breaks walls in chronic spontaneous urticaria

Presented By
Prof. Martin Metz, Charité Universitätsmedizin, Germany
Trial
Phase 1/2, BEACON
Conference
AAD 2025
Type
Peer-reviewed article

17 April 2025 15:34

Remibrutinib reduces itch, sleep problems, and activity impairment in patients with CSU

Presented By
Dr Ana Giménez-Arnau, Autonomous University and Pompeu Fabra University, Spain
Trial
Phase 2
Conference
EADV 2023
Type
Peer-reviewed article

28 November 2023 10:13

Biomarkers predicting response of different CSU treatments in children

Presented By
Mr Alex Nguyen, McGill University, Canada
Conference
AAD 2023
Type
Peer-reviewed article

15 May 2023 12:35

Autologous serum therapy benefits chronic spontaneous urticaria

Presented By
Dr Akash Agarwal, IMS and SUM Hospital Bhubaneswar, India
Conference
ICD 2021
Type
News article

2 December 2021 17:35

ICD 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ICD 2021

29 November 2021 09:20

CSU: Novel agent targeting Bruton’s tyrosine kinase leads to disease control

Presented By
Prof. Marcus Maurer, Charité University Hospital, Germany
Trial
Phase 2
Conference
EADV 2021
Type
Peer-reviewed article

18 November 2021 13:33

CSU: Ligelizumab likely safe and effective for adolescents

Presented By
Prof. BĂĽlent Ĺžekerel, Hacettepe University, Turkey
Trial
Phase 2
Conference
EADV 2021
Type
Peer-reviewed article

18 November 2021 13:29

Fenebrutinib at highest dose generally well tolerated

Conference
AAN 2021
Type
Peer-reviewed article

16 June 2021 11:49

Chronic inducible urticaria can require some detective work

Presented By
Prof. Marcus Maurer, Charité Universitätsmedizin Berlin, Germany
Trial
COLD-CE, CHED
Conference
EADV 2020

17 December 2020 14:28

Chronic spontaneous urticaria: hives, wheals & biomarkers

Presented By
Prof. Ana Giménez-Arnau, Autonomous University of Barcelona, Spain
Conference
EADV 2020
Type
Peer-reviewed article

17 December 2020 14:27

Ligelizumab for chronic spontaneous urticaria: a new star on the horizon

Presented By
Prof. Marcus Maurer, Charité Universitätsmedizin Berlin, Germany
Conference
EADV 2020
Type
Peer-reviewed article

17 December 2020 14:26

Comorbidities more common in chronic urticaria, psoriasis, and AD

Presented By
Dr Karsten Weller, Charité University Hospital, Germany
Conference
EADV 2019
Type
Peer-reviewed article

9 October 2019 20:40

D-Dimer as future biomarker in CSU management?

Presented By
Dr Antonio Cristaudo, San Gallicano Dermatological Institute, Italy
Conference
EADV 2019
Type
Peer-reviewed article

9 October 2019 18:41

Ligelizumab for CSU: symptom control and high response rates in re-treatment

Presented By
Prof. Marcus Maurer, Charité – Universitätsmedizin Berlin, Germany
Conference
EADV 2019
Type
Peer-reviewed article

9 October 2019 14:45

Novel anti-IgE drug enables durable urticaria control

Presented By
Dr Diane Baker, Baker Allergy, Asthma, and Dermatology Clinic, USA
Conference
AAD 2019
Type
Peer-reviewed article

19 April 2019 20:22
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com